EUVIMEDEUVIMED entdecken
Crossref

Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma

Deniz Bayçelebi, Mehmet Kefeli, Levent Yıldız, Filiz Karagöz

Polish Journal of Pathology · 10.01.2023 · 73 (3) · 233-243

DOI: 10.5114/pjp.2022.124478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Pathology, online erschienen am 10.01.2023. Verfasst von Deniz Bayçelebi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Ondokuz Mayls University Samsun, Atakum/Samsun, Turkey. Hauptthemen laut MEDLINE: Leiomyosarcoma, Leiomyoma, Uterine Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnostic criteria, biological behavior, and treatment approaches of leiomyosarcomas (LMS) may differ according to the origin of the tumor. This is important in terms of patient’s management, especially in tumors located in the peritoneum and retroperitoneal sites. In our study, we aimed to demonstrate the immunophenotypic characteristics of uterine and extra-uterine LMS using a large antibody panel, and to determine whether they potentially play a role in the differences among these tumor groups.

Between 2006 and 2018, 29 uterine and 42 extra-uterine primary LMS were included in this study. Using tissue samples taken from the areas that best represented the tumor, an immunohistochemical study was performed on the blocks prepared by tissue micro-array method with estrogen and progesterone receptor (PR), WT-1, SMA, desmin, caldesmon, calponin, p16, p53, MDM2, CDK4, bcl-2, cyclin D1, fascin, EMMPRIN, FOXM1, c-erb-B2, c-Myc, PAX8, and CD117. Staining results of uterine and extra-uterine LMS were evaluated with these 20 antibodies.

In uterine LMS compared with extra-uterine LMS, estrogen receptor (48% vs. 12%), PR (62% vs. 21%), desmin (79% vs. 50%), and EMMPRIN (69% vs. 45%) staining rate was detected higher. In extra-uterine LMS, caldesmon (88% vs. 69%), c-Myc (33% vs. 10%), and cyclin D1 (52% vs. 28%) were stained higher than uterine LMS (p < 0.05). No significant staining difference was detected with other antibodies.

We concluded that estrogen receptor, PR, desmin, EMMPRIN, caldesmon, c-Myc, and cyclin D1 antibodies may help to determine primary origin of the tumor in LMS cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyosarcomaLeiomyomaUterine NeoplasmsFemaleHumansBasiginCyclin D1Receptors, EstrogenDesminCalmodulin-Binding ProteinsBiomarkers, Tumor

Stichwörter der Autor:innen

extra-uterine.immunohistochemistryuterineleiomyosarcoma

Substanzen

BasiginCyclin D1Receptors, EstrogenDesminCalmodulin-Binding ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Ondokuz Mayls University Samsun, Atakum/Samsun, Turkey.

Zitieren

APA

Bayçelebi, D., Kefeli, M., Yıldız, L., & Karagöz, F. (2023). Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma. Polish Journal of Pathology, 73(3), 233-243. https://doi.org/10.5114/pjp.2022.124478

Vancouver

Bayçelebi D, Kefeli M, Yıldız L, Karagöz F. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma. Polish Journal of Pathology. 2023;73(3):233-243. doi:10.5114/pjp.2022.124478

BibTeX
@article{Bayelebi2023,
  author = {Bayçelebi, Deniz and Kefeli, Mehmet and Yıldız, Levent and Karagöz, Filiz},
  title = {Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma},
  journal = {Polish Journal of Pathology},
  year = {2023},
  volume = {73},
  number = {3},
  pages = {233--243},
  doi = {10.5114/pjp.2022.124478}
}
Kostenlos starten →